5DFV image
Deposition Date 2015-08-27
Release Date 2015-12-16
Last Version Date 2024-10-23
Entry Detail
PDB ID:
5DFV
Keywords:
Title:
CRYSTAL STRUCTURE OF HUMAN CD81 LARGE EXTRACELLULAR LOOP IN COMPLEX WITH MURINE FAB FRAGMENT K04
Biological Source:
Source Organism(s):
Homo sapiens (Taxon ID: 9606)
Mus musculus (Taxon ID: 10090)
Expression System(s):
Method Details:
Experimental Method:
Resolution:
2.80 Å
R-Value Free:
0.29
R-Value Work:
0.23
R-Value Observed:
0.24
Space Group:
P 1 21 1
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:CD81 antigen
Gene (Uniprot):CD81
Chain IDs:A, B
Chain Length:99
Number of Molecules:2
Biological Source:Homo sapiens
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:FAB HEAVY CHAIN
Chain IDs:C, E
Chain Length:222
Number of Molecules:2
Biological Source:Mus musculus
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:FAB LIGHT CHAIN
Chain IDs:D, F
Chain Length:218
Number of Molecules:2
Biological Source:Mus musculus
Primary Citation
VH-VL orientation prediction for antibody humanization candidate selection: A case study.
Mabs 8 288 305 (2016)
PMID: 26637054 DOI: 10.1080/19420862.2015.1117720

Abstact

Antibody humanization describes the procedure of grafting a non-human antibody's complementarity-determining regions, i.e., the variable loop regions that mediate specific interactions with the antigen, onto a β-sheet framework that is representative of the human variable region germline repertoire, thus reducing the number of potentially antigenic epitopes that might trigger an anti-antibody response. The selection criterion for the so-called acceptor frameworks (one for the heavy and one for the light chain variable region) is traditionally based on sequence similarity. Here, we propose a novel approach that selects acceptor frameworks such that the relative orientation of the 2 variable domains in 3D space, and thereby the geometry of the antigen-binding site, is conserved throughout the process of humanization. The methodology relies on a machine learning-based predictor of antibody variable domain orientation that has recently been shown to improve the quality of antibody homology models. Using data from 3 humanization campaigns, we demonstrate that preselecting humanization variants based on the predicted difference in variable domain orientation with regard to the original antibody leads to subsets of variants with a significant improvement in binding affinity.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback